Approval · Notice of Compliance 5454 · 1994
OCUFLOX: Notice of Compliance 5454
Issued November 25, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5454
- Date
- November 25, 1994
- Company
- Allergan IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antibacterial agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OCUFLOX | 02143291 | Marketed |
Medicinal ingredients
- OFLOXACIN 0.3 PER